Skip to content

Advertisement

Volume 17 Supplement 7

Selected articles from the 12th Annual Biotechnology and Bioinformatics Symposium: bioinformatics

  • Research
  • Open Access

A systematic framework to derive N-glycan biosynthesis process and the automated construction of glycosylation networks

  • 1Email author,
  • 3,
  • 2,
  • 1 and
  • 2
BMC BioinformaticsBMC series – open, inclusive and trusted201617 (Suppl 7) :240

https://doi.org/10.1186/s12859-016-1094-6

©  The Author(s) 2016

  • Published:

Abstract

Background

Abnormalities in glycan biosynthesis have been conclusively related to various diseases, whereas the complexity of the glycosylation process has impeded the quantitative analysis of biochemical experimental data for the identification of glycoforms contributing to disease. To overcome this limitation, the automatic construction of glycosylation reaction networks in silico is a critical step.

Results

In this paper, a framework K2014 is developed to automatically construct N-glycosylation networks in MATLAB with the involvement of the 27 most-known enzyme reaction rules of 22 enzymes, as an extension of previous model KB2005. A toolbox named Glycosylation Network Analysis Toolbox (GNAT) is applied to define network properties systematically, including linkages, stereochemical specificity and reaction conditions of enzymes. Our network shows a strong ability to predict a wider range of glycans produced by the enzymes encountered in the Golgi Apparatus in human cell expression systems.

Conclusions

Our results demonstrate a better understanding of the underlying glycosylation process and the potential of systems glycobiology tools for analyzing conventional biochemical or mass spectrometry-based experimental data quantitatively in a more realistic and practical way.

Keywords

  • N-glycan
  • Glycosylation reaction networks construction
  • Glycosylation enzyme activity
  • Mass spectrum
  • Glycobiology

Background

Glycosylation is an important and highly complex post-translational modification that generates an extensive functional capability from a limited set of genes and encompasses the biosynthesis of sugar moieties in the endoplasmic reticulum (ER) and Golgi apparatus [1–3]. Glycans are highly variable and structurally diverse compounds consisting of a large number of monosaccharides, including mannose, fucose, and galactose, linked through an enzymatic process called glycosylation [4]. Unlike protein structures, glycan structures are neither directly encoded in the genome nor arranged in a simple linear chain [5]. Instead, the structure of secreted and membrane-bound glycans is determined during their assembly in the endoplasmic reticulum and the Golgi apparatus by a controlled sequence of glycosyltransferase and glycosidase processing reactions [6].

One of the major types of glycans attached to asparagine residues of proteins, N-linked glycans, is determined by a manageable number of enzymes that catalyze monosaccharide attachment. N-linked glycosylation occurs co-translationally in endoplasmic reticulum compartments. Glycoproteins migrate into the Golgi apparatus once the protein finishes folding and some residues in the glycan trim successfully [7]. Many of these enzymes can generally accept several N-linked glycans as substrates, therefore generating a large number of glycan products and their glycosylation pathways [7]. Processing involves the removal of mannose groups, which is facilitated by mannosidases, and the addition of diverse monosaccharides driven by specific glycosyltransferases to the substrate glycan. Therefore, the glycosylation pathways of N-linked glycans comprise consecutive enzymatic steps, which are determined by the glycan structures produced by the previous enzyme, to produce a new glycan structure as the substrate of the next glycosylation reaction [7].

From research conducted in the past decades, it is clear that the glycosylation of diseased cells and healthy cells often results in different glycan changes that contribute to pathological progression, leading to the possibility that disease-specific glycan structures exist [8–12]. This has potential medical applications; for example, the potential to distinguish benign forms of prostate cancer from highly malignant cancer based on the changes in enzymes’ activities and intracellular processing events [13, 14]. Effective engineering of glycosylation pathways can potentially lead to an improved therapeutic performance of glycoprotein products. Considerable progress has been made in Prostate-Specific Antigen (PSA) research; and analytic approaches in analyzing large data sets have also been utilized to expand analyses from PSA to numerous cancers and diseases known to have abnormalities in glycosylation. However, more research is still needed in acquiring and interpreting datasets to completely characterize glycosylation, including enzymatic profiles involved in glycosylation and the large quantities of glycans produced by enzymes.

Fortunately, a wealth of data is available from glycosylation-specific databases such as the Consortium for Functional Glycomics (CFG) website [15] and GlycomeDB [16]. Also, Liquid Chromatography (LC) and Mass Spectrometric (MS) techniques have been emerging as enabling and important techniques in glycomics. A number of LC/MS methods have been incorporated into glycomics workflows for permethylated and aminated glycans reduction [17, 18]. Statistical methods have been proposed to predict glycan structures from gene expression data [19–21]. However, these traditional and qualitative methods in biochemistry or cell biology research do not provide a detailed understanding of the complex glycosylation mechanism quantitatively.

Systems biology-based mathematical models have been developed to overcome this limitation [6, 22–26]. In this regard, the construction of glycosylation reaction networks in silico is an important step that can enable the quantitative analysis of biochemical experimental data. Whereas several studies have been done to construct glycosylation reaction networks automatically on computers, they are limited by the lack of a systematic definition of the linkage, stereochemical specificity and reaction conditions of enzymes that are involved in the reactions.

Liu and Neelamegham [27] made a significant contribution by designing an open-source MATLAB-based toolbox, Glycosylation Network Analysis Toolbox (GNAT), for studies of systems glycobiology. This toolbox enables a streamlined machine-readable definition for the glycosylation enzyme class and the construction as well as adjustment of glycosylation reaction networks [27].

This paper extends Liu and Neelamegham’s work [27] to predict a wider range of glycans produced by enzymes encountered in human cell expression systems. In addition, our model can be applied to a larger range of experimental conditions that might be encountered in a cell culture environment. We expand the scope by inclusion of additional enzyme classes involved in gene expression data. We extend the framework of KB2005 [6] through involving 22 enzymes (27 enzyme reaction rules) in our network.

To the best of our knowledge, these 22 enzymes (27 enzyme reaction rules) are all enzymes associated with N-glycan that exist in Golgi compartments. Networks constructed can be used to relate the observed mass spectrometric measurements to the underlying gene expression weights. This relationship can be used to quantitatively understand how changes in enzymes’ activities affect the profile of glycan structures produced in the biosynthesis process.

Methods

We apply the Glycosylation Network Analysis Toolbox (GNAT) as the platform to facilitate the modeling. Generated by Liu and Neelamegham [27], GNAT is a MATLAB-based toolbox for the automated construction of glycosylation reaction networks.

Enzyme definitions using biological experimental data

To analyze biological experimental data in the glycomics field quantitatively, the construction of glycosylation reaction networks, which can describe the glycan biosynthesis process in silico, is rather critical. Some efforts have been made to build systems-level cellular glycosylation reaction networks on O-linked glycan [26] or N-linked glycan [23] formation. However, this work has always been hindered by the lack of a complete system for the specificity of detailed glycosylation rules. In this paper, we address this problem by defining enzymes in a machine-friendly way using a MATLAB-based toolbox called Glycosylation Network Analysis Toolbox (GNAT).

In GNAT, we can define generic enzymes using the Enz class. Since the properties of transferases and hydrolases are very different, TfEnz and HlEnz are used as subclasses of the Enz class to define them, respectively, as follows:

Transferase reaction:
$$donor+acceptor \leftrightharpoons donorProd + acceptorProd $$
Hydrolase reaction:
$$substrate + H_{2}O \leftrightharpoons prod\_oh +prod\_h $$
where donor, donorProd, acceptor and acceptorProd are variables used to specify properties in transferase (T f E n z) reactions and p r o d_o h and p r o d_h are for hydrolase (H l E n z) reactions as named.

In addition, variables such as r e s f u n c g r o u p, linkFG, r e s A t t2F G and l i n k A t t2F G are used to specify functional groups and linkage specificity for enzymes. More specifically, resfuncgroup is the residue of functional group transferred, r e s A t t2F G is the residue attaching to functional group, l i n k F G refers to the linkage between attaching residue and functional group and l i n k r e s A t t2F G stands for the linkage between the attaching residue and its next neighboring residue.

Most importantly, eight substrate specificity functions are available in the glycosyltransferase and glycosidase classes: substMinStruct, substMaxStruct, substNABranch, substNAStruct, substNAResidue, targetBranch, targetNABranch, and isTerminalTarget. They define the properties of substrates or products in reactions upon which a specific enzyme acts. Only if all conditions defined by these functions are satisfied can the corresponding enzyme act on the substrate; that is, the reaction will happen. In this work, firstly, we collect 27 enzyme reaction rules of 22 enzymes from databases, such as GlycomeDB [16], KEGG Glycan, IUBMB (International Union of Biochemistry and Molecular Biology), GlycoGene DataBase (ggdb), the Consortium for Functional Glycomics (CFG) website [25], and previous work by Sandra V. Bennun et al. [24] (See Table 1). Secondly, we define enzymes by specifying their properties in biosynthesis reactions utilizing the functions above (See Figs. 1 and 2).
Fig. 1
Fig. 1

Part of enzyme reaction rules defined in class G T E n z/G H E n z (part 1). Blank fields indicate that we do not need to define the value of this variable of the corresponding enzyme

Fig. 2
Fig. 2

Part of enzyme reaction rules defined in class G T E n z/G H E n z (part 2). Blank fields indicate that we do not need to define the value of this variable of the corresponding enzyme

Table 1

Current enzyme reaction rules

Index

Enzyme

EC No.

Substrate

Product

Constraint

1

ManI

[3.2.1.113]

(Ma2Ma

(Ma

\(\thicksim \)*2Ma3(...Ma6)

2

ManI

[3.2.1.113]

(Ma3(Ma2Ma3(Ma6)Ma6)

(Ma3(Ma3(Ma6)Ma6)

 

3

ManII

[3.2.1.114]

(Ma3(Ma6)Ma6

(Ma6Ma6

(GNb2 |Ma3 & \(\thicksim \)Gnbis)

4

ManII

[3.2.1.114]

(Ma6Ma6

(Ma6

(GNb2 |Ma3 & \(\thicksim \)Gnbis)

5

FUT8

[2.4.1.68]

GNb4GN

GNb4(Fa6)GN

GNb2 |Ma3 & \(\thicksim \)Gnbis & \(\thicksim \)Ab

6

MGAT1

[2.4.1.101]

(Ma33(Ma3(Ma6)Ma6)Mb4

(GNb2Ma3(Ma3(Ma6)Ma6)Mb4

 

7

MGAT2

[2.4.1.143]

(GNb2|Ma3(Ma6)Mb4

(GNb2 |Ma3(GNb2Ma6)Mb4

 

8

MGAT3

[2.4.1.144]

GNb2 |Ma3

GNb2 |Ma3(GNb4)

\(\thicksim \)Ab & \(\thicksim \)Gnbis

9

MGAT4

[2.4.1.145]

(GNb2Ma3

(GNb2(GNb4)Ma3

\(\thicksim \)Gnbis

10

MGAT5

[2.4.1.155]

(GNb2Ma6

(GNb2(GNb6)Ma6

\(\thicksim \)Gnbis

11

iGnT

[2.4.1.149]

(Ab4GN

(GNb3Ab4GN

\(\thicksim \)_Ma3 |Mb4

12

b4GalT

[2.4.1.38]

(GN

(Ab4GN

(\(\thicksim \)*GNb4)(…Ma6)Mb4

13

a3SiaT

[2.4.99.6]

(Ab4GN

(NNa3Ab4GN

 

14

IGNT

[2.4.1.150]

(Ab4GNb3Ab

(Ab4GNb3(GNb6)Ab

 

15

a6SiaT

[2.4.99.1]

(Ab4GN

(NNa6Ab4GN

 

16

b3GalT1

[2.4.1.62]

(GN

(Ab3GN

(\(\thicksim \)*GNb4)(…Ma6)Mb4

17

FUT3

[2.4.1.65]

Ab3GNb

Ab3(Fa4)GNb

(Ab3* or (Fa2Ab3* or (NNa3Ab3*)

18

FUT3

[2.4.1.65]

(…Ab4GNb

(Fa3(…Ab4)GNb

(*Ab4 or (*Fa2Ab4 or (*NNa3Ab4)

19

FUT1

[2.4.1.69]

(Ab3GNb

(Fa2Ab3GNb

 

20

FUT1

[2.4.1.69]

(Ab4GNb

(Fa2Ab4GNb

 

21

a3FucT

[2.4.1.152]

(…Ab4GNb

(Fa3(…Ab4)GNb

(*Ab4 or (*Fa2Ab4

22

GalNAcT-A

[2.4.1.40]

(Fa2Ab

(Fa2(ANa3)Ab

 

23

GalT-B

[2.4.1.37]

(Fa2Ab

(Fa2(Aa3)Ab

 

24

b3GALT6

[2.4.1.134]

Ab4GN

Ab3Ab4GN

 

25

b3GALT6

[2.4.1.134]

Ab4A

Ab3Ab4A

 

26

c1GALT1

[2.4.1.122]

AN

Ab3AN

 

27

st3galI

[2.4.99.4]

(Ab3GN

(NNa3Ab4GN

 

Automated construction of glycosylation reaction networks

We integrate glycosyltransferase and glycosidase enzymatic data from databases into across-the-board enzyme classes: GHEnz and GTEnz. Automated construction of glycosylation reaction networks is enabled by the definition of the glycosidase (GHEnz) and glycosyltransferase (GTEnz) classes. If the substrate and the enzyme are determined, the product of glycosidase and glycosyltransferse reactions can be automatically generated by function product inference. Here we choose the function forward network inference, which can consider the products generated as the substrates of the next reaction so that reactions will happen in a sequential manner if the reaction conditions conform to the enzyme reaction rules. This is repeated until no additional new products are generated by the set of enzymes specified.

In this work, we define all enzymes in file createEnzDb.m (See “Availability of data and materials” section for the MATLAB codes) and then load it in MATLAB. Next, we place all enzymes in a CellArrayList object called enzArray. Starting with the glycan CellArrayList objects 9-mannose and 8-mannose as substrates, all possible reaction pathways and products are determined by function inferGlyForwPath. This process will continue indefinitely if there are always reactions and products. In this process, duplicate reactions and glycan product species are removed while being consolidated into the Pathway object. In the network generated by our model (called K2014), nodes represent the glycan species and the biochemical reactions between two glycans are denoted as edges. Setting the value of the variable count, we can easily limit the size of the network generated as needed.

Results

We applied the 27 current reaction rules of biosynthesis reactions catalyzed by 22 enzymes to define all these enzymes. These definitions were then used to infer an N-linked glycosylation reaction network automatically in MATLAB. The network generated shows all enzymes catalyzing each reaction in different colors. All reactions are denoted as arrows, which are determined by the enzyme that catalyzed them. Glycan structures involving linkages and monosaccharides that constitute the glycan are also visual. We call this network K2014, as shown in Fig. 3. The comparison among previous models UB1997 [22], KB2005 [23], and our model K2014 is shown in Table 2 (only in the first seven rounds because from the eighth round, our network becomes too big to be presented here). Since pathways can be generated endlessly if reactions are still possible to happen according to the reaction rules, we can set round in the for loop and get a network of the size we need. At the same time, we can also operate the network generated by removing glycans that do not exist in the Golgi apparatus using the pathway class.
Fig. 3
Fig. 3

Reaction network generated by model K2014. This is the glycosylation reaction network automatically generated by our model K2014 which takes M9 as the substrate and involves all 27 enzyme reaction rules (only the first seven rounds are shown here)

Table 2

A comparison among the reaction networks generated by previous models UB1997, KB2005, and our model K2014 (First 7 rounds)

Model

UB 1997

KB2005

K2014

Number of enzymes

8

11

22

Number of structures

4

14

31

Number of reactions

12

26

64

Discussion

As can be seen from Table 2, our model generates a much more complex glycosylation reaction network. Here we consider one horizontal step as one round. Take round 7 as an example. In the model UB1997 [22] where only eight enzymes are considered, there are only four glycan structures in the network. Three monosaccharides are operated in this network: mannose, N-acetylglucosamine, and galactose. While in 2005, 11 enzymes are involved in the model KB2005 and 14 structures can be shown in round 7. In this model, the network shows the glycosylation process containing five monosaccharides being added to or cut from the visual glycan structures. However, in reality, the structures of glycan can be much more complicated, and more monosaccharides can be added to a glycan during the glycosylation process regarding enzyme specificity.

Concerning the fact that more enzyme reaction rules have been updated by biologists, we take the most up-to-date reaction rules into concern and involve them all in the construction of a glycosylation reaction network. From previous research [28–46], we know that all of these enzymes make contributions to the glycosylation process and should therefore be included into the construction of a glycosylation reaction network. Thus, the model K2014 is built. There are many more glycan structures than we have space to show here. As can be seen from Fig. 3, 31 glycan structures have been generated by the catalysis of these 22 enzymes (totally 27 enzyme reaction rules). Note that it provides a more complete understanding of the glycosylation process. The enzymatic rules collected from databases and literature show that these enzymes exist in cells and are involved in the glycosylation process. Concerning that our network includes more enzymes than the original GNAT and the model KB2005 [23], it is closer to reality. Thus, our model provides a result that better represents the underlying glycosylation process.

Conclusions

In this work, we extend the model KB2005 [23] with application of the toolbox GNAT to construct a relatively larger N-linked glycosylation network. While GNAT only involves the presence of 9 enzymes, we include 22 enzymes (totally 27 enzyme reaction rules) whose information is collected from the literature, glycosylation-specific databases such as GlycomeDB [16], the Consortium for Functional Glycomics (CFG) website [25], KEGG Glycan and ggdb. Our framework K2014 can automatically construct a relatively larger glycosylation reaction network using 27 streamlined enzyme reaction rules. Accordingly, this framework advances the study of the in silico cell processes and potentially has significant benefits.

With this glycosylation network and related algorithms, a variety of network analysis strategies can be implemented to analyze the components of the overall glycosylation network. With our framework K2014, it is possible to analyze conventional biochemical or mass spectrometry-based experimental data quantitatively in a more realistic and practical way. Examples include, but are not limited to, a dynamic mathematical model for monoclonal antibodies (mAbs) glycosylation to estimate unknown enzymes and transport proteins (TPs) concentration profile parameters [47], a framework to quantitatively understand how changes in enzymes activities affect the profile of glycan structures produced in the biosynthesis process [24], and the simulations on N-glycan processing in accessing whether a homogeneous glycan profile can be created through metabolic engineering [48]. Future research can be conducted on the above-related issues using both conventional biochemical resources and high-throughput MS experimental data.

Declarations

Acknowledgements

The authors would like to thank the referees and the editors for their helpful comments and suggestions. This research work was supported by Research Grants Council of Hong Kong under Grant Number 17301214, HKU CERG Grants, Hung Hing Ying Physical Research Grant, the Natural Science Foundation of China under Grant No. 11271144. Publication of this article was funded by Soka University (52021200).

Declarations

This article has been published as part of BMC Bioinformatics Volume 17 Supplement 7, 2016: Selected articles from the 12th Annual Biotechnology and Bioinformatics Symposium: bioinformatics. The full contents of the supplement are available online at https://bmcbioinformatics.biomedcentral.com/articles/supplements/volume-17-supplement-7.

Availability of data and materials

Here follows the MATLAB codes for the construction of glycosylation networks.

File 1 – createEnzDb.m. This file defines all enzymes.

Please refer to this link to download it: http://hkumath.hku.hk/~wkc/Hou/createEnzDb.m.

File 2 – glyenzDB.mat. This file should be loaded before running codes.

Please refer to this link to download it: http://hkumath.hku.hk/~wkc/Hou/glyenzDB.mat.zip.

File 3 – runme. This file contains the codes we should run on MATLAB.

Please refer to this link to download it: http://hkumath.hku.hk/~wkc/Hou/runme.rtf.

File 4 – readme.txt.

Please refer to the link to download it: http://hkumath.hku.hk/~wkc/Hou/readme.txt.

Authors’ contributions

KK designed the research and gave basic ideas for the method. WH developed and implemented the method, performed theoretical analyses and computational experiments, and drafted and revised the manuscript. NH assisted WH in implementing the method. WKC participated in discussions and gave valuable comments to improve the draft. YQ assisted in data presentation. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the CreativeCommons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Mathematics, The University of Hong Kong, Hong Kong, 999077, China
(2)
Faculty of Science and Engineering, Soka University, Tokyo 192–8577, Japan
(3)
Hematology Oncology Division, Northwestern University, Evanston, IL 60208, USA

References

  1. Pattison RJ, Amtmann A. N-glycan production in the endoplasmic reticulum of plants. Trends Plant Sci. 2009; 14(2):92–9.View ArticlePubMedGoogle Scholar
  2. Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell. 2006; 126(5):855–67.View ArticlePubMedGoogle Scholar
  3. Brooks SA. Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins. Expert Rev Proteomics. 2006; 3(3):345–59.View ArticlePubMedGoogle Scholar
  4. IUPAC Gold Book- Glycans. http://goldbook.iupac.org/G02645.html.
  5. von der Lieth CW, Bohne-Lang A, Lohmann KK, Frank M. Bioinformatics for glycomics: status, methods, requirements and perspectives. Brief Bioinform. 2004; 5(2):164–78.View ArticlePubMedGoogle Scholar
  6. Krambeck FJ, Bennun SV, Narang S, Choi S, Yarema KJ, Betenbaugh MJ. A mathematical model to derive N-glycan structures and cellular enzymes’ activities from mass spectrometric data. Glycobiology. 2009; 19(11):1163–75.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Kim PJ, Lee DY, Jeong H. Centralized modularity of N-linked glycosylation pathways in mammalian cells. PLoS One. 2009; 4(10):7317.View ArticleGoogle Scholar
  8. Sell S. Cancer-associated carbohydrates identified by monoclonal antibodies. Hum Pathol. 1990; 21(10):1003–19.View ArticlePubMedGoogle Scholar
  9. Hakomori S. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol. 2001; 491:369–402.View ArticlePubMedGoogle Scholar
  10. Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat Rev Cancer. 2005; 5(7):526–42.View ArticlePubMedGoogle Scholar
  11. Tong L, Baskaran G, Jones MB, Rhee JK, Yarema KJ. Glycosylation changes as markers for the diagnosis and treatment of human disease. Biotechnol Genet Eng Rev. 2003; 20(1):199–244.View ArticlePubMedGoogle Scholar
  12. Dennis JW, Granovsky M, Warren CE. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta. 1999; 1473(1):21–34.View ArticlePubMedGoogle Scholar
  13. Tajiri M, Ohyama C, Wada Y. Oligosaccharide profiles of the prostate specific antigen in free and complexed forms from the prostate cancer patient serum and in seminal plasma: A glycopeptide approach. Glycobiology. 2008; 18(1):2–8.View ArticlePubMedGoogle Scholar
  14. Meany DL, Zhang Z, Sokoll LJ, Zhang H, Chan DW. Glycoproteomics for prostate cancer detection: Changes in serum PSA glycosylation patterns. J Proteome Res. 2009; 8(2):613–9.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Raman R, Venkataraman M, Ramakrishnan S, Lang W, Raguram S, Sasisekharan R. Advancing glycomics: Implementation strategies at the consortium for functional glycomics. Glycobiology. 2006; 16(5):82–90.View ArticleGoogle Scholar
  16. Ranzinger R, Herget S, Lieth CWVD, Frank M. GlycomeDB-A unified database for carbohydrate structures. Nucleic Acids Res. 2011; 39 (Database issue):373–6.View ArticleGoogle Scholar
  17. Zaia J. Mass spectrometry and the emerging field of glycomics. Chem Biol. 2008; 15(9):881–92.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Novotny MV, Alley WR. Recent trends in analytical and structural glycobiology. Curr Opin Chem Biol. 2013; 17(5):832–40.View ArticlePubMedGoogle Scholar
  19. Suga A, Yamanishi Y, Hashimoto K, Goto S, Kanehisa M. An improved scoring scheme for predicting glycan structures from gene expression data. Genome Inform. 2007; 18:237–46.PubMedGoogle Scholar
  20. Hashimoto K, Goto S, Kawano S, Aoki-Kinoshita KF, Ueda N, Hamajima M, Kawasaki T, Kanehisa M. KEGG as a glycome informatics resource. Glycobiology. 2006; 16(5):63–70.View ArticleGoogle Scholar
  21. Kawano S, Hashimoto K, Miyama T, Goto S, Kanehisa M. Prediction of glycan structures from gene expression data based on glycosyltransferase reactions. Bioinformatics. 2005; 21(21):3976–82.View ArticlePubMedGoogle Scholar
  22. Umana P, Bailey JE. A mathematical model of N-linked glycoform biosynthesis. Biotechnol Bioeng. 1997; 55(6):890–908.View ArticlePubMedGoogle Scholar
  23. Krambeck FJ, Betenbaugh MJ. A mathematical model of N-linked glycosylation. Biotechnol Bioeng. 2005; 92(6):711–28.View ArticlePubMedGoogle Scholar
  24. Bennun SV, Yarema KJ, Betenbaugh MJ, Krambeck FJ. Integration of the transcriptome and glycome for identification of glycan cell signatures. PLoS Comput Biol. 2013; 9(1):1002813.View ArticleGoogle Scholar
  25. Puri A, Neelamegham S. Understanding glycomechanics using mathematical modeling: A review of current approaches to simulate cellular glycosylation reaction networks. Ann Biomed Eng. 2012; 40(4):816–27.View ArticlePubMedGoogle Scholar
  26. Liu G, Marathe DD, Matta KL, Neelamegham S. Systems-level modeling of cellular glycosylation reaction networks: O-linked glycan formation on natural selectin ligands. Bioinformatics. 2008; 24(23):2740–7.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Liu G, Neelamegham S. A computational framework for the automated construction of glycosylation reaction networks. PLoS One. 2014; 9(6):100939.View ArticleGoogle Scholar
  28. Yip B, Chen S, Mulder H, Hoppener J, Schachter H. Organization of the human β-a,2-N-acetylglucosaminyltransferase I gene (MGAT1), which controls complex and hybrid N-glycan synthesis. Biochem J. 1997; 321:465–74.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Tan J, D’agostaro G, Bendiak B, Reck F, Sarkar M, Squire J, Leong P, Schachter H. The human UDP-N-acetylglucosamine: α-6-D-mannoside- β-1, 2-N-acetylglucosaminyltransferase II gene (MGAT2). Eur J Biochem. 1995; 231:317–28.View ArticlePubMedGoogle Scholar
  30. Yoshida A, Minowa M, Takamatsu S, Hara T, Oguri S, Ikenaga H, Takeuchi M. Tissue specific expression and chromosomal mapping of a human UDP-N-acetylglucosamine: α1,3-D-mannoside β1, 4-N-acetylglycosaminyltransferase. Glycobiology. 1999; 9(3):303–10.View ArticlePubMedGoogle Scholar
  31. Yoshida A, Minowa M, Takamatsu S, Hara T, Ikenaga H, Takeuchi M. A novel second isoenzyme of the human UDP-N-acetylglucosamine: α1, 3-D-mannoside β1, 4-N-acetylglucosaminyltransferase family: cDNA cloning, expression, and chromosomal assignment. Glycoconjugate J. 1998; 15:1115–23.View ArticleGoogle Scholar
  32. Larsen R, Ernst L, Nair R, Lowe J. Molecular cloning, sequence, and expression of a human GDP-L-fucose: β-D-galactoside 2- α-L-fucosyltransferase cDNA that can form the H blood group antigen. Proc Nat Acad Sci USA. 1990; 87:6674–8.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Amado M, Almeida R, Carneiro F, Levery S, Holmes E, Nomoto M, Hollingsworth M, Hassan H, Schwientek T, Nielsen P, Bennett E, Clausen H. A family of human β3-galactosyltransferases. J Biol Chem. 1998; 273(21):12770–8.View ArticlePubMedGoogle Scholar
  34. Ju T, Brewer K, D’Souza A, Cummings R, Canfield W. Closing and expression of human core 1 β1,3-galactosyltransferase. J Biol Chem. 2002; 277(1):178–86.View ArticlePubMedGoogle Scholar
  35. Ihara Y, Nishikawa A, Tohma T, Soejima H, Niikawa N, Taniguchi N. cDNA cloning, expression, and chromosomal localization of human N-acetylglucosaminyltransferase III (GnT-III). J Biochem. 1993; 113:692–8.PubMedGoogle Scholar
  36. Oulmouden A, Wierinckx A, Petit J, Costache M, Palcic M, Mollicone R, Oriol R, Julien R. Molecular cloning and expression of a bovine α(1,3)-fucosyltransferase gene homologous to a putative ancestor gene of the human FUT3-FUT5-FUT6 cluster. J Biol Chem. 1997; 272(12):8764–73.View ArticlePubMedGoogle Scholar
  37. Shiraishi N, Natsume A, Togayachi A, Endo T, Akashima T, Yamada Y, Imai N, Nakagawa S, Koizumi S, Sekine S, Narimatsu H, Sasaki K. Identification and characterization of three novel β1, 3-N-acetylglucosaminyltransferases structurally related to the β-1, 3-galactosyltransferase family. J Biol Chem. 2001; 276(5):3498–507.View ArticlePubMedGoogle Scholar
  38. Inaba N, Hiruma T, Togayachi A, Iwasaki H, Wang X, Furukawa Y, Sumi R, Kuso T, Fujimura K, Iwai T, Gotoh M, Nakamura M, Narimatsu H. A novel I-branching β-1, 6-N-acetylglucosaminyltransferase involved in human blood group I antigen expression. Blood. 2003; 101(7):2870–6.View ArticlePubMedGoogle Scholar
  39. Inamori K, Endo T, Ide Y, Fujii S, Gu J, Honke K, Taniguchi N. Molecular cloning and characterization of human GnT-IX, a novel β1, 6-N-acetylglucosaminyltransferase that is specifically expressed in the brain. J Biol Chem. 2003; 278(44):43102–9.View ArticlePubMedGoogle Scholar
  40. Almeida R, Amado M, David L, Levery S, Holmes E, Merkx G, van Kessel AG, Rygaard E, Hassan H, Bennett E, Clausen H. A family of human β4-galactosyltransferases. J Biol Chem. 1997; 272(51):31979–91.View ArticlePubMedGoogle Scholar
  41. Voynow J, Kaiser R, Scanlin T, Glick M. Purification and characterization of GDP-L-fucose-N-acetyl β-D-glycosaminide α1→6 fucosyltransferase from cultured human skin fibroblasts. J Biol Chem. 1991; 266(32):21575–7.Google Scholar
  42. Nakayama F, Nishihara S, Iwasaki H, Kudo T, Okubo R, Kaneko M, Nakamura M, Karube M, Sasaki K, Narimatsu H. CD15 expression in mature granulocytes is determined by α1, 3-fucosyltransferase IX, but in promyelocytes and monocytes by α1, 3-fucosyltransferase IV. J Biol Chem. 2001; 276(19):16100–6.View ArticlePubMedGoogle Scholar
  43. Bai X, Zhou D, Brown J, Crawford B, Hennet T, Esko J. Biosynthesis of the linkage region of glycosaminoglycans. J Biol Chem. 2001; 276(51):48189–95.PubMedGoogle Scholar
  44. Takashima S, Tsuji S, Tsujimoto M. Characterization of the second type of human β-galactoside α2,6-sialyltransferase (ST6Gal II), which sialylates Gal β1, 4GlcNAc structures on oligosaccharides preferentially. J Biol Chem. 2002; 277(48):45719–28.View ArticlePubMedGoogle Scholar
  45. Kitagawa H, Paulson J. Cloning of a novel α2, 3-sialytransferase that sialylates glycoprotein and glycolipid carbohydrate groups. J Biol Chem. 1994; 269(2):1394–401.PubMedGoogle Scholar
  46. Kitagawa H, Paulson JC. Differential expression of five sialyltransferase genes in human tissues. J Biol Chem. 1994; 269(27):17872–8.PubMedGoogle Scholar
  47. del Val IJ, Nagy JM, Kontoravdi C. A dynamic mathematical model for monoclonal antibody N-linked glycosylation and nucleotide sugar donor transport within a maturing Golgi apparatus. Biotechnol Prog. 2011; 27(6):1730–43.View ArticleGoogle Scholar
  48. Hossler P, Mulukutla B, Hu W. Systems analysis of N-glycan processing in mammalian cells. PLoS One. 2007; 2(8):713.View ArticleGoogle Scholar

Copyright

© The Author(s) 2016

Advertisement

BMC Bioinformatics

ISSN: 1471-2105

Contact us